Skip to main content
Clinical Trials/NCT01278836
NCT01278836CompletedPhase 2

Study of Fasciocutaneous Flaps for Treatment of Leg Defects

Isfahan University of Medical Sciences1 site in 1 country23 target enrollmentStarted: June 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
23
Locations
1
Primary Endpoint
necrosis

Study Overview

Brief Summary

The purpose of this study is to determine the effects of fasciocutaneous flaps for leg defects.

Detailed Description

The fasciocutaneous flaps are tissue flaps which include skin, subcutaneous tissue, and the underlying fascia. Including the deep fascia with its prefascial and subfascial plexus enhances the circulation of these flaps. The investigators determined long-term outcomes of fasciocutaneous flap reconstruction in patients with lower limb defects.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • patients with leg defects

Exclusion Criteria

  • patients with underlying diseases

Outcomes

Primary Outcomes

necrosis

Time Frame: at three years after surgery

Secondary Outcomes

  • venous congestion(at three years after surgery)

Investigators

Study Sites (1)

Loading locations...

Similar Trials